Bigfoot Biomedical Stock

bigfootbiomedical.comHealthcareFounded: 2014Funding to Date: $92.5MM

Bigfoot Biomedical is a medical device company developing technologies to significantly reduce the cognitive, emotional, and financial burden of insulin-requiring diabetes. Founded in 2014 by a team of people with personal connections to type 1 and type 2 diabetes with the vision to create a world where technology frees people from the burdens of living with insulin-requiring diabetes, Bigfoot Biomedical is headquartered in Milpitas, California.

Register for Details

For more details on financing and valuation for Bigfoot Biomedical, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Bigfoot Biomedical.

Register Today

Bigfoot Biomedical investors also invested in these private companies

Taiwania Capital
Visionnaire Ventures
Agrocorp Ventures
Madryn Asset Management
W Investments Group
Smile Group
Abbott Ventures
Endo Investors
Janus Henderson Investors
Cormorant Asset Management
Harvey Partners
Quadrant Capital Advisors
Senvest Capital

Team

Management Team

Bryan Mazlish
Co-Founder & President
Brett Hale
Chief Financial Officer
Ian Hanson
Chief Technology Officer
Jeffrey Brewer
Co-Founder & Chief Executive Officer
James Malone
Chief Medical Officer
Matt Rainville
Chief Commercial Officer

Board Members

Thomas Brener
Quadrant Capital Advisors

Other companies like Bigfoot Biomedical in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
 
 
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$4.26B
Sector
 
 

News

Press Release Bigfoot Biomedical announced today that its innovative Bigfoot Unity™ Diabetes Management Program is now available to diabetes clinics and endocrinology practices in select markets across the U.S. The groundbreaking program reimagines how clinicians...
Press Release Bigfoot Biomedical, a company dedicated to better health outcomes for people with insulin-requiring diabetes, announced today that the FDA has granted 510(k) clearance for first-of-its-kind Bigfoot Unity™ Diabetes Management System, which features connected...
Bigfoot Biomedical, a Milpitas, CA-based company dedicated to health outcomes for people with insulin-requiring diabetes, secured new debt and equity financing of up to $57m from Madryn Asset Management